Biomarker analysis in Castleman's disease, TAFRO syndrome, and those related diseases

Biomarker analysis in Castleman's disease, TAFRO syndrome, and those related diseases - Biomarker analysis in Castleman's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034188

Enrollment

Registered

2018-09-19

Start date

2018-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Castleman&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Castleman's disease or TAFRO syndrome who satisfy a diagnostic criteria proposed by Ministry of Health, Labour and Welfare (MHLW) Policy Research on Intractable Diseases "A survey study based on international consensus building for the development and further improvement of medical guidelines for Castleman's disease, TAFRO syndrome and related diseases (Team Kawakami) " and patients who are difficult to distinguish from those diseases.

Exclusion criteria

Exclusion criteria: Patients judged inappropriate as subjects of research.

Design outcomes

Primary

Measure	Time frame
Identification of biomarkers that contribute to the establishment of diagnosis of Castleman's disease, TAFRO syndrome, and those related diseases	—

Countries

Japan

Contacts

Public ContactTomohiro Koga

Nagasaki University Graduate School of Biomedical Sciences Department of Immunology and Rheumatology

tkoga@nagasaki-u.ac.jp0958197262

Outcome results